Product Wiki · Recalls · EU Safety Gate (RAPEX)

Ringset — recall A12/03455/24

EU Safety Gate (RAPEX) · Sweden · 2024-12-06 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/03455/24
Date of alert
2024-12-06
Country / jurisdiction
Sweden
Risk level
Serious risk
Risk type
Chemical
Brand
Tinka Beauty
Product category
Jewellery
Product type
Ring set
Barcode (EAN/GTIN)
7036574336316
Reported risk: Produkten har en för hög halt av kadmium (uppmätt värde: upp till 75 viktprocent). Kadmium är skadligt för människors hälsa eftersom det ackumuleras i kroppen, kan skada njurar och ben och kan orsaka cancer. Produkten uppfyller inte kraven i REACH-förordningen.
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Withdrawal of the product from the market
Date of entry into force
17/07/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Risk Description (original English): The product has an excessive concentration of cadmium (measured value: up to 75 % by weight). Cadmium is harmful to human health because it accumulates in the body, can damage the kidneys and bones and it may cause cancer.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10092359

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.